OBJECTIVE: Sexual function among testicular cancer survivors is a concern because affected men are of reproductive age when diagnosed. We conducted a case-control study among United States military men to examine whether testicular cancer survivors experienced impaired sexual function. METHODS: A total of 246 testicular cancer cases and 236 ethnicity and age matched controls were enrolled in the study in 2008-2009. The Brief Male Sexual Function Inventory (BMSFI) was used to assess sexual function. RESULTS: Compared to controls, cases scored significantly lower on sex drive (5.77 vs. 5.18), erection (9.40 vs. 8.63), ejaculation (10.83 vs. 9.90), and problem assessment (10.55 vs. 9.54). Cases were significantly more likely to have impaired erection (OR 1.72; 95% CI 1.11-2.64), ejaculation (OR 2.27; 95% CI 1.32-3.91), and problem assessment (OR 2.36; 95% CI 1.43-3.90). In histology and treatment analysis, nonseminoma, chemotherapy and radiation treated cases risk of erectile dysfunction, delayed ejaculation, and/or problem assessment were greater when compared to controls. CONCLUSION: This study provides evidence that testicular cancer survivors are more likely to have impaired sexual functioning compared to demographically matched controls. The observed impaired sexual functioning appeared to vary by treatment regimen and histologic subtype.
OBJECTIVE: Sexual function among testicular cancer survivors is a concern because affected men are of reproductive age when diagnosed. We conducted a case-control study among United States military men to examine whether testicular cancer survivors experienced impaired sexual function. METHODS: A total of 246 testicular cancer cases and 236 ethnicity and age matched controls were enrolled in the study in 2008-2009. The Brief Male Sexual Function Inventory (BMSFI) was used to assess sexual function. RESULTS: Compared to controls, cases scored significantly lower on sex drive (5.77 vs. 5.18), erection (9.40 vs. 8.63), ejaculation (10.83 vs. 9.90), and problem assessment (10.55 vs. 9.54). Cases were significantly more likely to have impaired erection (OR 1.72; 95% CI 1.11-2.64), ejaculation (OR 2.27; 95% CI 1.32-3.91), and problem assessment (OR 2.36; 95% CI 1.43-3.90). In histology and treatment analysis, nonseminoma, chemotherapy and radiation treated cases risk of erectile dysfunction, delayed ejaculation, and/or problem assessment were greater when compared to controls. CONCLUSION: This study provides evidence that testicular cancer survivors are more likely to have impaired sexual functioning compared to demographically matched controls. The observed impaired sexual functioning appeared to vary by treatment regimen and histologic subtype.
Authors: G Jonker-Pool; H B Van de Wiel; H J Hoekstra; D T Sleijfer; M F Van Driel; J P Van Basten; H S Schraffordt Koops Journal: Arch Sex Behav Date: 2001-02
Authors: F Joly; J F Héron; L Kalusinski; P Bottet; D Brune; N Allouache; J Macé-Lesec'h; J E Couëtte; J Pény; M Henry-Amar Journal: J Clin Oncol Date: 2002-01-01 Impact factor: 44.544
Authors: Katherine A McGlynn; Susan S Devesa; Alice J Sigurdson; Linda M Brown; Lilian Tsao; Robert E Tarone Journal: Cancer Date: 2003-01-01 Impact factor: 6.860
Authors: Noa Shani Shrem; Lori Wood; Robert J Hamilton; Kopika Kuhathaas; Piotr Czaykowski; Matthew Roberts; Andrew Matthew; Jason P Izard; Peter Chung; Lucia Nappi; Jennifer Jones; Denis Soulières; Armen Aprikian; Nicholas Power; Christina Canil Journal: Can Urol Assoc J Date: 2022-08 Impact factor: 2.052
Authors: Jennifer A Soon; Angelyn Anton; Javier Torres; Ruth Lawrence; Phillip Parente; Joseph McKendrick; Ian D Davis; Carmel Pezaro Journal: Support Care Cancer Date: 2018-10-22 Impact factor: 3.603
Authors: Jason K Gurney; Andrea A Florio; Ariana Znaor; Jacques Ferlay; Mathieu Laversanne; Diana Sarfati; Freddie Bray; Katherine A McGlynn Journal: Eur Urol Date: 2019-07-17 Impact factor: 20.096
Authors: Paolo Capogrosso; Luca Boeri; Matteo Ferrari; Eugenio Ventimiglia; Giovanni La Croce; Umberto Capitanio; Alberto Briganti; Rocco Damiano; Francesco Montorsi; Andrea Salonia Journal: Asian J Androl Date: 2016 Jan-Feb Impact factor: 3.285
Authors: Michael A Hoyt; Ashley Wei-Ting Wang; Sean J Ryan; Elizabeth C Breen; Jennifer S Cheavens; Christian J Nelson Journal: Trials Date: 2020-04-14 Impact factor: 2.279